Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet / lymphocyte ratio relationship with disease severity and metabolic syndrome in patients with psoriasis vulgaris

Aim: Psoriasis is one of the diseases caused by chronic inflammation. It is associated with a number of comorbidities (metabolic syndrome, cardiovascular disease, obesity, non-alcholic fatty liver...). Recently, mean platelet volume (MPV), neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) were found to be related to systemic inflammation. At the end of this study, the risk of metabolic syndrome in psoriasis will be evaluated and the effect of MPV, NLR, PLR levels will be determined on predicting metabolic comorbidities in psoriasis patients.Material and Methods: This research was planned prospectively. The study consisted of 40 patients with psoriasis vulgaris and 40 healty control group which was similar in age and gender . Patients' informations were recorded and blood pressure, height, weight values were measured. Hemogram parameters, biochemistry values were determined.Results: The count of neutrophiles was higher in the psoriasis; but disease severity and neutrophil count were not related each other. According to our study, MPV values, high density lipoprotein (HDL), fasting blood glucose and body mass index (BMI) were meaningful findings in estimating the development of metabolic syndrome. Conclusion: The use of neutrophil activation markers in addition to neutrophil count in patients with psoriasis may be useful in determining disease severity and activation. In the follow-up of patients with psoriasis, fasting glucose, HDL, BMI value and MPV can help predicting possibility of metabolic syndrome and cardiovascular diseases that may develop in these patients.

PDF

___

1. Cerman AA, Karabay EA, Altunay IK. Psoriazisli hastalarda nötrofil lenfosit oranı ve ortalama trombosit hacminin değerlendirilmesi. Med Bull Sisli Etfal Hosp 2016;50:137-41.
2. Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012;5:2.
3. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007;154:995-1002.
4. Walsh SR, Cook EJ, Goulder F, et al. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181-4.
5. Turkmen D, Altunisik N, Sener S. Investigation of monocyte HDL ratio as an indicator of inflammation and complete blood count parameters in patients with acne vulgaris [published online ahead of print,2020 Aug 2]. Int J Clin Pract 2020;10:1111
6. An I, Ucmak D.Evaluation of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in patients with psoriasis vulgaris. Dicle Med J 2018;45:327-34.
7. Paliogiannis P, Satta R, Deligia G, et al. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and metaanalysis. Clin Exp Med 2019;19:37-45.
8. Sarac G, Mantar I, Sener S, et al. Assessment of change in neutrophil-lymphocyte ratio, plateletlymphocyteratio in patients with acute and chronic . Ann Med Res 2018;25:719-22.
9. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17:47-58.
10. Altunisik N, Turkmen D, Sener S. Investigation of the relationship between inflammatory blood parameters and rosacea and demodex infestation. J Cosmet Dermatol 2020;19:2105-8.
11. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010;8:148-56.
12. Suárez-Fariñas M, Li K, Fuentes-Duculan J, et al. Expanding the psoriasis disease profile: Interrogation of the skin and serum of patients with moderate-tosevere psoriasis. J Invest Dermatol 2012;132:2552- 64.
13. Gisondi P, Fostini AC, Fossà I, et al. Psoriasis and the metabolic syndrome.Clin Dermatol 2018;36:21-8.
14. Sen BB, Rifaioglu EN, Ekiz O, et al. Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis.Cutan Ocul Toxicol 2014;33:223-7.
15. An I, Ucmak D, Ozturk M. The effect of biological agent treatment on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in psoriasis patients. Postepy Dermatol Alergol 2020;37:202-6.
16. Nobari NN, Dadras MS, Nasiri S, et al. Neutrophil/ platelet to lymphocyte ratio in monitoring of response to TNF-α inhibitors in psoriatic patients . Dermatol Ther 2020.
17. Kim DS, Lee J, Kim SH, et al. Mean platelet volume is elevated in patients with psoriasis vulgaris.Yonsei Med J 2015;56:712-8.
18. An I, Ucmak D, Ozturk M, et al. Neutrophil / lymphocyte ratio, platelet / Iymphocyte ratio, mean platelet volume and C-reactive protein values in psoriatic arthritis patients. Ann Med Res 2019;26:894-8.
19. Chandrashekar L, Rajappa M, Revathy G, et al. Is enhanced platelet activation the missing link leading to increased cardiovascular risk in psoriasis? Clin Chim Acta 2015;446:181-5.
20. Dogan S, Atakan N. Red Blood Cell Distribution Width is a Reliable Marker of Inflammation in Plaque Psoriasis. Acta Dermatovenerol Croat 2017;25:26-31.
21. Sarac G, Altunisik N, Sener S et al. Evaluation of changes in neutrophil-lymphocyte ratio and plateletlymphocyte ratio in patients with vitiligo. Ann Med Res 2019;26:1344-6.
22. Kim DS, Shin D, Jee H, et al. Red blood cell distribution width is increased in patients with psoriasis vulgaris: A retrospective study on 261 patients. J Dermatol 2015;42:567-71.
23. Unal M, Kucuk A, Unal GU, et al. Psoriasiste ortalama trombosit hacmi, nötrofil/lenfosit oranı ve trombosit/ lenfosit oranı. Turkderm 2015;49:112-6.
24. Zindanci I, Albayrak O, Kavala M, et al. Prevalence of metabolic syndrome in patients with psoriasis. Sci World J 2012;2012:312463.
25. Milčić D, Janković S, Vesić S, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study. An Bras Dermatol 2017;92:46-51.
26. Mallbris L, Granath F, Hamsten A, et al. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006;54:614-21.
27. Buyukkaya E, Karakas MF, Karakas E, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost 2014;20:159-63.
28. Bahadir A, Baltaci D, Türker Y, et al. Is the neutrophilto- lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? Anatol J Cardiol 2015;15:816-22.